Showing results (121-130 of 163) with videos related to
Sort By:
Pageof 17
Oncoimmunology|April 11, 2018
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomideSerena Pellegatta, Marica Eoli, Valeria Cuccarini, et al.Journal of Cancer Survivorship : Research and Practice|May 4, 2023
Late-onset vascular complications of radiotherapy for primary brain tumors: a case-control and cross-sectional analysisMaría-José Ibáñez-Juliá, Alberto Picca, Delphine Leclercq, et al.Journal of Cancer Policy|August 27, 2023
European Cancer Organisation Essential Requirements for Quality Cancer Care: Adult gliomaAlessandro Bozzao, Damien Weber, Simon Crompton, et al.Journal of Neuro-Oncology|May 4, 2023
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumorsElisabetta Lazzarini, Domenico Alessandro Silvestris, Giuseppe Benvenuto, et al.EMBO Reports|November 18, 2016
Resetting cancer stem cell regulatory nodes upon MYC inhibitionSilvia Galardi, Mauro Savino, Fiorella Scagnoli, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 23, 2021
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experienceLuca Diamanti, Alberto Picca, Paola Bini, et al.Neurology(R) Neuroimmunology & Neuroinflammation|February 27, 2021
Longitudinally Extensive Myelitis Associated With Immune Checkpoint InhibitorsAlberto Picca, Giulia Berzero, Kevin Bihan, et al.Nature Communications|October 5, 2016
A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathwaysTianzhi Huang, Angel A Alvarez, Rajendra P Pangeni, et al.Neuro-Oncology Advances|July 10, 2020
Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapyMarica Eoli, Cristina Corbetta, Elena Anghileri, et al.Journal of Neuro-Oncology|December 10, 2014
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumabAnna Luisa Di Stefano, Marianne Labussiere, Giuseppe Lombardi, et al.Pageof 17